IRIS Accounts Production v24.1.4.33 15237800 director 26.10.23 29.2.24 29.2.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh152378002023-10-25152378002024-02-29152378002023-10-262024-02-29152378002023-10-2515237800ns14:PoundSterling2023-10-262024-02-2915237800ns10:Director12023-10-262024-02-2915237800ns10:PrivateLimitedCompanyLtd2023-10-262024-02-2915237800ns10:SmallEntities2023-10-262024-02-2915237800ns10:AuditExempt-NoAccountantsReport2023-10-262024-02-2915237800ns10:SmallCompaniesRegimeForDirectorsReport2023-10-262024-02-2915237800ns10:SmallCompaniesRegimeForAccounts2023-10-262024-02-2915237800ns10:FullAccounts2023-10-262024-02-2915237800ns10:CompanySecretary12023-10-262024-02-2915237800ns10:RegisteredOffice2023-10-262024-02-2915237800ns5:ShareCapital2024-02-2915237800ns5:RetainedEarningsAccumulatedLosses2024-02-2915237800ns5:AdditionsToInvestments2024-02-2915237800ns5:CostValuation2024-02-29
REGISTERED NUMBER: 15237800















Unaudited Financial Statements

for the Period 26 October 2023 to 29 February 2024

for

Larx Capital Management Ltd

Larx Capital Management Ltd (Registered number: 15237800)






Contents of the Financial Statements
for the Period 26 October 2023 to 29 February 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Larx Capital Management Ltd

Company Information
for the Period 26 October 2023 to 29 February 2024







DIRECTOR: J Solich





SECRETARY:





REGISTERED OFFICE: C/O Holtram Tlpi Ltd Trident House
Trident Business Park
Didcot
OX11 7HJ





REGISTERED NUMBER: 15237800





ACCOUNTANTS: Nixon Williams Limited
Apollo House
Hallam Way
Whitehills Business Park
Blackpool
FY4 5FS

Larx Capital Management Ltd (Registered number: 15237800)

Statement of Financial Position
29 February 2024

Notes £    £   
FIXED ASSETS
Investments 4 17,748

CURRENT ASSETS
Investments 5 191,833
Cash at bank 38,980
230,813
NET CURRENT ASSETS 230,813
TOTAL ASSETS LESS CURRENT
LIABILITIES

248,561

CAPITAL AND RESERVES
Called up share capital 100
Retained earnings 248,461
248,561

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 29 February 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 29 February 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 16 August 2024 and were signed by:





J Solich - Director


Larx Capital Management Ltd (Registered number: 15237800)

Notes to the Financial Statements
for the Period 26 October 2023 to 29 February 2024

1. STATUTORY INFORMATION

Larx Capital Management Ltd is a private company, limited by shares , registered in Not specified/Other. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

4. FIXED ASSET INVESTMENTS
Shares in
group Other
undertakings investments Totals
£    £    £   
COST OR VALUATION
Additions 68 17,680 17,748
At 29 February 2024 68 17,680 17,748
NET BOOK VALUE
At 29 February 2024 68 17,680 17,748

Larx Capital Management Ltd (Registered number: 15237800)

Notes to the Financial Statements - continued
for the Period 26 October 2023 to 29 February 2024

4. FIXED ASSET INVESTMENTS - continued

Cost or valuation at 29 February 2024 is represented by:

Shares in
group Other
undertakings investments Totals
£    £    £   
Valuation in 1 68 17,680 17,748

5. CURRENT ASSET INVESTMENTS
£   
Listed investments 191,833